Kura Oncology (KURA) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Kura Oncology (KURA) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 5, 2023 (17:07)

Sector: Healthcare

The share price of Kura Oncology, Inc. (KURA) now

Latest session on the 5th of December for
Kura Oncology, Inc. is positive
Trading Volume: 531199
Open: 10.09 /  High: 10.9 /  Low: 10.078
What analysts predict: $28.21
52-week High/Low: $16.14 / $7.41

50/200 Day Moving Average: $8.75 / $10.68

This figure corresponds to the Average Price over the previous 50/200 days. For Kura Oncology stocks, the 50-day moving average is the support level today.

For Kura Oncology stocks, the 200-day moving average is the resistance level today.

Are you interested in Kura Oncology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Kura Oncology stock price in 2023, 2024, 2025, 2026, 2027. How much will one Kura Oncology share be worth in 2023 - 2027?

When should I take profit in Kura Oncology stock? When should I record a loss on Kura Oncology stock? What are analysts' forecasts for Kura Oncology stock? What is the future of Kura Oncology stock? We forecast Kura Oncology stock performance using neural networks based on historical data on Kura Oncology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Kura Oncology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Kura Oncology shares. This happens once a day.




Historical and forecast chart of Kura Oncology stock

The chart below shows the historical price of Kura Oncology stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Kura Oncology stock price can be found in the table below.

Long-term forecasts by years.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Kura Oncology daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 07 10.59 10.48 10.65 1.67
Dec 08 10.63 10.45 10.82 3.53
Dec 09 10.39 10.25 10.55 2.84
Dec 10 10.26 10.12 10.36 2.41
Dec 11 10.21 10.07 10.41 3.40
Dec 12 10.17 10.09 10.26 1.71
Dec 13 10.16 9.96 10.30 3.42
Dec 14 10.04 9.93 10.20 2.70
Dec 15 10.07 9.99 10.27 2.77
Dec 16 10.12 9.95 10.23 2.80
Dec 17 9.98 9.78 10.09 3.21
Dec 18 10.10 9.98 10.18 2.00
Dec 19 10.25 10.05 10.35 3.04
Dec 20 10.43 10.30 10.57 2.56
Dec 21 10.54 10.49 10.66 1.68
Dec 22 10.68 10.55 10.76 2.02
Dec 23 10.94 10.85 11.12 2.44
Dec 24 10.99 10.79 11.21 3.87
Dec 25 10.92 10.74 11.13 3.63
Dec 26 10.79 10.66 10.98 2.96
Dec 27 10.85 10.64 10.91 2.55
Dec 28 10.78 10.73 10.88 1.43
Dec 29 10.79 10.70 11.01 2.90
Dec 30 10.82 10.72 10.98 2.45
Dec 31 10.80 10.65 10.87 2.08
Jan 01 10.84 10.66 11.04 3.58
Jan 02 10.96 10.83 11.05 2.00
Jan 03 10.71 10.64 10.84 1.94
Jan 04 10.60 10.46 10.71 2.41
Jan 05 10.49 10.36 10.56 1.97

Kura Oncology Daily Price Targets


Kura Oncology Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $10.59.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.641%.
Pessimistic target level: 10.48
Optimistic target level: 10.65

Kura Oncology Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $10.63.
Positive dynamics for Kura Oncology shares will prevail with possible volatility of 3.413%.
Pessimistic target level: 10.45
Optimistic target level: 10.82

Kura Oncology Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $10.39.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 2.760%.
Pessimistic target level: 10.25
Optimistic target level: 10.55

Kura Oncology Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $10.26.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 2.351%.
Pessimistic target level: 10.12
Optimistic target level: 10.36

Kura Oncology Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $10.21.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 3.286%.
Pessimistic target level: 10.07
Optimistic target level: 10.41

Kura Oncology Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $10.17.
Negative dynamics for Kura Oncology shares will prevail with possible volatility of 1.686%.
Pessimistic target level: 10.09
Optimistic target level: 10.26

KURA (KURA) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Dec. 9.24 8.33 9.78 14.86

Kura Oncology forecast for this year


Kura Oncology Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $9.24365. Pessimistic: $8.33. Optimistic: $9.78



Kura Oncology (KURA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 10.05 9.50 10.47 9.24
Feb 9.97 9.46 11.01 14.01
Mar 9.23 8.45 10.07 16.09
Apr 8.18 7.88 8.81 10.61
May 7.87 7.22 8.27 12.62
Jun 8.26 7.41 8.90 16.76
Jul 8.40 7.52 9.26 18.74
Aug 8.37 7.93 8.78 9.67
Sep 7.77 7.24 8.26 12.36
Oct 7.19 6.57 7.86 16.40
Nov 7.05 6.36 7.64 16.78
Dec 7.22 6.89 7.88 12.51

Kura Oncology (KURA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 7.05 6.79 7.48 9.20
Mar 6.70 6.43 7.37 12.76
Mar 6.39 5.79 6.85 15.41
Apr 6.00 5.67 6.29 9.80
May 5.84 5.59 6.33 11.64
Jun 5.81 5.56 6.04 8.01
Jul 5.97 5.38 6.42 16.30
Aug 5.42 4.86 5.63 13.76
Sep 5.48 5.21 6.00 13.18
Oct 4.89 4.56 5.23 12.88
Nov 4.82 4.62 5.04 8.33
Dec 4.53 4.20 4.77 11.97

Kura Oncology (KURA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 5.07 4.87 5.34 8.77
Mar 5.46 5.29 5.91 10.56
Mar 5.67 5.20 5.95 12.62
Apr 5.90 5.63 6.35 11.24
May 5.72 5.32 6.02 11.72
Jun 5.96 5.79 6.50 10.84
Jul 6.49 6.05 6.91 12.45
Aug 6.76 6.50 7.05 7.85
Sep 7.62 7.37 8.15 9.49
Oct 8.10 7.87 8.54 7.89
Nov 8.53 7.64 9.17 16.68
Dec 8.16 7.85 8.53 7.96

Kura Oncology (KURA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 8.97 8.41 9.60 12.39
Mar 9.51 9.02 10.40 13.20
Mar 8.43 7.89 8.70 9.32
Apr 8.73 8.18 9.29 11.96
May 9.21 8.41 9.86 14.70
Jun 9.48 9.18 9.87 6.99
Jul 10.29 9.82 10.97 10.48
Aug 11.54 10.85 12.58 13.82
Sep 12.48 12.12 13.55 10.54
Oct 13.88 12.94 14.24 9.12
Nov 14.47 13.45 15.64 13.96
Dec 15.43 14.71 15.99 8.03

Kura Oncology information and performance

Kura Oncology Address

3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CA, US

Market Capitalization: 688 131 000 $

Market capitalization of the Kura Oncology, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KURA shares in the company outstanding by the market price of one share.

EBITDA: -153 356 992 $

EBITDA of Kura Oncology is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.02

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -3.404

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 74272000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.